Accelerating the path to first-in-human clinical trials

Our Head of Drug Substance, Paul Quigley, was recently interviewed by Outsourcing Pharma to coincide with his presentation at CPhI North America 2019. He explained the importance of ensuring rapid delivery and how integrated services and technological investment help to achieve this.

You can read the full article on the Outsourcing Pharma website